Cardionovum

Be up
to date.

Latest press release

Dr. Lichtenberg discusses about Aperto® drug-coated balloon technology and its promising results in dialysis access patients

Prof. Michael Lichtenberg (Arnsberg, Germany) speaks to Vascular News at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2022 annual meeting in Barcelona (Spain) about the importance on new endovascular strategies, such as Drug-Coated Balloons (DCBs), to improve patency rates in patients with consecutive neointimal hyperplasia in haemodialysis access.

 

In this interview, a particular focus is put on the promising results of APERTO® OTW, our high-pressure paclitaxel releasing DCB, considered as “one of the very promising new technologies” for treating restenosis in dialysis access patients

Learn more >>

Late-Breaking Xlimit RCT data presented at CSC Congress demonstrate an equivalent performance of the Xlimus® DES in terms of OCT derived endpoints than the Synergy™ DES.

Bonn, Germany. November 16, 2022 – Data presented at Innovation session today at the CSC 2022 congress demonstrated an equivalent performance of the Xlimus® DES in terms of OCT derived endpoints than the Synergy™ DES, including Neointimal Volume and Neointimal Volume weighted by length at 6 months. Secondary endpoints, including other OCT parameters, such as in-stent Minimum Lumen Area (MLA) and percentage of strut coverage as well as clinical endpoints, showed no significant differences between the two groups in any of the evaluated parameters within the Xlimit RCT.

Learn more >>

Prof. Matteo Tozzi discusses about new data bolster safety and effectiveness of Safepax®

Prof. Matteo Tozzi (Varese, Italy) speaks to Vascular News at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2022 annual meeting in Barcelona (Spain) about his new study that analyzes the concentrations of paclitaxel in the bloodstream after the use of a Drug-Coated Balloons (DCBs) in AVFs.

Learn more >>

CARDIONOVUM® announces regulatory approval of APERTO® OTW in Mexico

We are proud to announce that we have received the authorization by the Secretaria de Salud and COFEPRIS to distribute APERTO® OTW in Mexico.

Learn more >>

Cardionovum® announces First Procedure in Hyper II International Clinical Trial.

CARDIONOVUM® today announced the enrollment of the first patient in the International Hyper II Clinical Study

Learn more >>

CARDIONOVUM® announces the first Signature RCT patient enrollment

On June 8th, in Sankt Gertrauden hospital in Berlin, Germany, the first Signature RCT patient has been enrolled

Learn more >>

Upcoming events

Cardionovum® at CIRSE 2025

Cardionovum® is pleased to invite you to visit us at booth #1.

Location:

CCIB Conference Centre
Plaça de Willy Brandt, 11 -14
08019 Barcelona
Spain

Date: Sep 13, 2025–Sep 17, 2025

Latest events

Cardionovum® at LINC 2024

Cardionovum® is pleased to invite you to visit us at booth #309.

Location:

Leipziger Messe GmbH
Messe-Allee 1
04356 Leipzig

Date: May 28, 2024–June 01, 2024

Cardionovum® at EuroPCR 2024

Cardionovum® is pleased to invite you to visit us at booth #M14.

Location:

Palais des Congrès de Paris
2 Place Porte Maillot
Paris - FRANCE

Date: May 14, 2024–May 18, 2024

Cardionovum® at 12 Westdeutsches Gefäßsymposium

Cardionovum® is pleased to invite you to visit us at our booth during the Westdeutsches Gefäßsymposium.

Location:

Congress Centrum Oberhausen
Düppelstraße 1
46045 Oberhausen, Germany

Date: Feb 16, 2024–Feb 18, 2024

go top